Back to Screener

Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

Price$9.05

Favorite Metrics

Price vs S&P 500 (4W)-29.76%
Market Capitalization$915.93M

All Metrics

P/CF (Annual)53.64x
Book Value / Share (Quarterly)$6.10
P/TBV (Annual)3.05x
Price vs S&P 500 (YTD)-51.13%
Gross Margin (TTM)15.40%
Net Profit Margin (TTM)-4.60%
EPS (TTM)$-0.48
10-Day Avg Trading Volume0.85M
EPS Excl Extra (TTM)$-0.48
EPS (Annual)$-0.49
ROI (Annual)-3.22%
Gross Margin (Annual)15.40%
Cash / Share (Quarterly)$0.61
Revenue Growth QoQ (YoY)7.95%
ROA (Last FY)-2.67%
EBITD / Share (TTM)$0.56
Operating Margin (TTM)8.25%
Cash Flow / Share (Annual)$-0.07
P/B Ratio1.56x
P/B Ratio (Quarterly)2.83x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)0.31x
EPS Incl Extra (Annual)$-0.49
Current Ratio (Annual)1.27x
Quick Ratio (Quarterly)1.17x
3-Month Avg Trading Volume0.87M
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$5.67
P/S Ratio (Annual)0.90x
Asset Turnover (Annual)0.58x
52-Week High$19.45
EPS Excl Extra (Annual)$-0.49
Quick Ratio (Annual)1.17x
13-Week Price Return-39.76%
Total Debt / Equity (Annual)1.50x
Current Ratio (Quarterly)1.27x
Enterprise Value$1,734.055
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-3.15%
Cash / Share (Annual)$0.61
3-Month Return Std Dev100.00%
Net Income / Employee (TTM)$-0
ROE (Last FY)-8.04%
Net Interest Coverage (Annual)0.31x
EPS Basic Excl Extra (Annual)$-0.49
Total Debt / Equity (Quarterly)1.50x
EPS Incl Extra (TTM)$-0.48
P/S Ratio (TTM)0.90x
Revenue / Share (Annual)$10.64
Tangible BV / Share (Annual)$5.67
Forward P/E11.91x
Year-to-Date Return-48.49%
5-Day Price Return2.47%
EPS Normalized (Annual)$-0.49
Net Profit Margin (Annual)-4.60%
Month-to-Date Return10.81%
EBITD / Share (Annual)$0.57
Operating Margin (Annual)8.25%
LT Debt / Equity (Annual)1.40x
P/CF (TTM)53.64x
LT Debt / Equity (Quarterly)1.40x
EPS Basic Excl Extra (TTM)$-0.48
P/TBV (Quarterly)3.05x
P/B Ratio (Annual)2.83x
Pretax Margin (TTM)-3.15%
Book Value / Share (Annual)$6.10
Price vs S&P 500 (13W)-40.45%
Beta2.46x
P/FCF (Annual)70.71x
Revenue / Share (TTM)$10.16
52-Week Low$7.23

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
4.17
4.25
4.36

Industry Peers — Health Services(21)

SymbolP/E Ratio (Annual)Revenue Growth TTM (YoY)Operating Margin (TTM)ROE (TTM)Price
LMRILumexa Imaging Holdings, Inc. Common Stock
8.25%$9.05
NTRANatera, Inc. Common Stock
35.90%-13.44%-15.28%$196.11
LHLabcorp Holdings Inc.
25.08x7.25%9.92%10.28%$266.36
DGXQuest Diagnostics Inc.
21.24x11.78%14.10%13.88%$191.46
EXASExact Sciences Corp
17.69%-6.35%-8.51%$104.91
GHGuardant Health, Inc. Common Stock
32.88%-45.02%-246.60%$85.70
RDNTRadNet, Inc. Common Stock
1779.27x11.51%3.04%-1.88%$60.09
VCYTVeracyte, Inc.
40.04x16.01%11.17%5.33%$33.03
GRALGRAIL, Inc. Common Stock
17.18%-381.98%-17.11%$49.47
CDNACareDx, Inc.
18.34x13.79%-8.10%-6.47%$22.42
FTREFortrea Holdings Inc. Common Stock
1.00%-32.04%-152.17%$10.09

About

Lumexa Imaging Holdings Inc is a diagnostic imaging services provider offering a comprehensive range of modalities including MRI, CT, PET, X-ray, ultrasound, and mammography. The company operates through two segments: Outpatient Imaging Centers, which generates the majority of revenue by performing imaging studies and providing radiologist interpretations, and Professional Services, which interprets studies conducted by external facilities such as hospitals.